Interestingly, research has demonstrated that ITGB3 can regulate expression of matrix metalloproteinase 2 (MMP2) [120], a protein that is critical in the inflammatory response and in demyelinating diseases, such as MS [121,122,123]. This evidence concerns the gene ITGB3 and myeloid sarcoma.